Lycopodium clavatum

LYCOPODIUM CLAVATUM SPORE ORAL HUMAN OTC DRUG

Lycopodium clavatum is an FDA drug label for the active ingredient LYCOPODIUM CLAVATUM SPORE manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231113.

Generic name
LYCOPODIUM CLAVATUM SPORE
Manufacturer
Boiron
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
0220-3183
Application
N/A
Label effective
20231113

Active ingredients

Lycopodium clavatum 7C (**contains 0.443 mg of the active ingredient per pellet)

Indications & Usage

Bloated Abdomen Improved By Passing Gas*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.